RTL
ACET icon

Red Tortoise LLC’s Adicet Bio ACET Stock Holding History

Red Tortoise LLC’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-41
Closed -$1.58K – 549
2023
Q2 		$1.58K Buy
+41
New +$3.62K ﹤0.01% 499

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Red Tortoise LLC's ACET Position: Q3 2023 in Review

Red Tortoise LLC sold out of Adicet Bio (ACET) in Q3 2023, closing a stake of 41 shares — an estimated $1.58K sold.

Red Tortoise LLC first reported a position in ACET in Q2 2023 and held it in 1 quarter. The position peaked at $1.58K in Q2 2023. 83 funds tracked by Wall St. Rank hold ACET as of Q3 2023.

  • Red Tortoise LLC reported no remaining Adicet Bio position as of Q3 2023 after selling out during the quarter.
  • Red Tortoise LLC sold 41 Adicet Bio shares in Q3 2023, an estimated $1.58K.
  • Red Tortoise LLC first reported a position in Adicet Bio in Q2 2023 and held it in 1 quarter.
  • Red Tortoise LLC's Adicet Bio position peaked at $1.58K in Q2 2023.
  • 83 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2023.

Based on Red Tortoise LLC's 13F filing for Q3 2023, filed 2 Nov 2023.